ADVANCED SOLID MALIGNANCIES
Clinical trials for ADVANCED SOLID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mitochondrial vaccine trial launches for Hard-to-Treat cancers
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a new type of vaccine made from engineered mitochondria, designed to help the immune system attack cancer cells. It is for people with advanced solid tumors who have no other standard treatment options. The main goal is to check safety, but researcher…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: West China Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 03:59 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing a new drug called AZD9574, either alone or with other cancer medicines, in people with advanced solid tumors that have grown or come back after standard treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can …
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for advanced cancer patients: BC2027 enters early human testing
Disease control Recruiting nowThis early-phase study tests a new drug called BC2027 in 180 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants must be in fairly good …
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for advanced cancers: experimental drug BMS-986523 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called BMS-986523, either alone or with other cancer medicines, in people with advanced solid tumors (like lung, colon, or pancreatic cancer) that have a specific genetic change (KRAS). The main goals are to see if the drug is safe and to fin…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 13, 2026 16:02 UTC